Nordic Food Panel 96 IgG - SERUM - ENGLISH

Overview

The Nordic Food Panel 96 IgG offers insights into serum IgG antibody reactivity to 96 commonly consumed foods spanning categories such as grains, dairy, meats, fish, fruits, vegetables, nuts, seeds, herbs, spices, and yeasts. This information can support individuals and practitioners interested in understanding potential delayed food responses that might influence wellbeing over time. Such responses might not be immediately noticeable and could emerge hours or days after consuming certain foods, making it challenging to pinpoint relevant dietary factors.

This panel may be particularly useful for those exploring general digestive comfort, nutritional balance, energy levels, skin health, and overall lifestyle considerations. It provides a broad overview that can contribute to personal dietary awareness and support mindful eating practices. Practitioners commonly integrate these findings with detailed lifestyle, dietary history, food rotation habits, and elimination approaches to help build a comprehensive picture of individual food response patterns.

Interpretation is typically made in the context of each person’s unique experiences, timing of symptoms, and other lifestyle factors. The Nordic Food Panel 96 IgG facilitates a wider look at food-related immune activity aligned with personal wellness goals and health optimisation strategies. This approach encourages informed decision-making around nutrition without implying diagnostic or clinical conclusions.

Nordic Food Panel 96 IgG measures serum IgG responses to 96 commonly consumed foods to provide an overview of delayed food-related immune activity.

Nordic Food Panel 96 IgG is intended for informational, educational, wellness and/or research purposes only. It is not intended for use in medical diagnosis, disease screening or clinical decision-making. Nordic Food Panel 96 IgG is not a replacement for clinical laboratory testing and does not provide medical diagnoses. This content is intended for general information within the EU market and should not be interpreted as a regulated in-vitro diagnostic claim.